OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 18, 2016
The company’s method reduces the time required to crystallize antibodies from weeks to one day.
May 16, 2016
Combining powder micro-dosing services with the Xcelodose technology, Capsugel offers capabilities in both North America and Europe.
May 15, 2016
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing
May 10, 2016
The GPhA and its Biosimilars Council expressed concern about the new proposed value-based reimbursement rules for Part B medications.
Phase I clinical trials of PfSPZ revealed it may protect healthy adults, who have not been exposed to Malaria before, for more than on year.
May 04, 2016
The production of antibody-drug conjugates requires biopharmaceutical and chemical manufacturing, and conjugation capabilities.
MilliporeSigma expands its Carlsbad, California-based GMP capacity for viral and gene-therapy products by nearly 90%.
May 02, 2016
Safe handling of HPAPIs requires determining exposure potential and selecting appro-priate containment strategies.
Experts discuss some of the emerging trends in bioprocessing in 2016, including 4D bioprinting, 2D-NMR, and the CAR-T design space.
Bioprocess operations-from cell line selection to final filtration-can influence the consistency and purity of biologic drug substances.